Related Experiment Video
Updated: Oct 24, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Molecular docking analysis of compounds from Andrographis paniculata with EGFR
1Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu-600077, India.
This study investigated the molecular docking of five compounds from Andrographis paniculata against the Epidermal Growth Factor Receptor (EGFR), a key factor in oral cancer. The findings highlight potential interactions for future therapeutic development.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Epidermal Growth Factor Receptor (EGFR) is implicated in the development and progression of oral cancer.
- Andrographis paniculata is a medicinal plant with potential anti-cancer properties.
Purpose of the Study:
- To perform molecular docking analysis of five key compounds from Andrographis paniculata against EGFR.
- To evaluate the binding interactions of these compounds with EGFR for potential therapeutic applications in oral cancer.
Main Methods:
- Molecular docking simulations were employed to analyze the binding affinity and mode of interaction.
- The study focused on five specific compounds: 14-acetylandrographolide, andrograpanin, andrographolide, isoandrographolide, and neoandrographolide.
Main Results:
- The molecular docking analysis revealed distinct binding features and interactions between the selected Andrographis paniculata compounds and EGFR.
- Specific compounds demonstrated promising binding characteristics, suggesting potential inhibitory effects on EGFR activity.
Conclusions:
- The identified binding interactions provide a basis for further investigation of Andrographis paniculata compounds as potential therapeutic agents against oral cancer.
- These findings warrant further preclinical and clinical studies to validate the efficacy of these compounds in targeting EGFR.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025